Development and internal validation of a macrophage migration inhibitory factor-based risk assessment model for delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage
JianBo Zhang, ChengMing Bao, AnKui Lu, Kun Guo · 2026
Read Development and internal validation of a macrophage migration inhibitory factor-based risk assessment model for delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage by JianBo Zhang, ChengMing Bao, AnKui Lu, Kun Guo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13619806.txt.
Description
JianBo Zhang and co-authors build a risk model for a feared complication of brain hemorrhage in a 2026 study. After an aneurysm bursts, delayed cerebral ischemia can strike days later and wreck outcomes. An inflammation regulator in the blood, macrophage migration inhibitory factor, might flag who is heading that way.
One hundred patients with aneurysmal bleeding were tracked during their hospital stay, and twenty-eight developed the complication. Admission blood levels of the factor joined scans and clinical features in a regression model. The team turned the result into a nomogram, a bedside scoring chart, and checked its accuracy and usefulness on the same patients.
Catalog record
| CREATOR | JianBo Zhang, ChengMing Bao, AnKui Lu, Kun Guo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |